Literature DB >> 29321516

Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.

Jun-Hui Yuan1, Akihiro Hashiguchi1, Yuji Okamoto1, Akiko Yoshimura1, Masahiro Ando1, Kazutaka Shiomi2, Kayoko Saito3, Makoto Takahashi4, Keiko Ichinose4, Takuma Ohmichi5, Kazushi Ichikawa6, Adachi Tadashi7, Hiroshi Takigawa7, Hidehiro Shibayama8, Hiroshi Takashima9.   

Abstract

SH3TC2, known as the causative gene of autosomal recessive demyelinating Charcot-Marie-Tooth type 4C (CMT4C), was also found linked to a mild mononeuropathy of the median nerve with an autosomal dominant inheritance pattern. Using DNA microarray, Illumina MiSeq, and Ion proton, we carried out gene panel sequencing among 1483 Japanese CMT patients, containing 397 patients with demyelinating CMT. From seven patients with demyelinating CMT, we identified eight recessive variants in the SH3TC2 gene, consisting of five novel (pathogenic/likely pathogenic) and three reported variants. Additionally, from two patients with axonal CMT, we detected a reported recessive variant, p.Arg77Trp, which was herein reclassified as variant with unknown significance. Of the seven CMT4C patients (six females and one male), 2/7 patients developed symptoms at their first decade, and 5/7 patients lost their ambulation around age 50. Scoliosis was observed from more than half (4/7) of these patients, whereas hearing loss is the most common symptom of central nervous system (6/7). No median nerve mononeuropathy was recorded from their family members. We identified recessive variants in SH3TC2 from 1.76% of demyelinating CMT patients. An uncommon gender difference was recognized and the wild spectrum of these variants suggests mutational diversity of SH3TC2 in Japan.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29321516     DOI: 10.1038/s10038-017-0388-5

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Clinical and mutational spectrum of Japanese patients with Charcot-Marie-Tooth disease caused by GDAP1 variants.

Authors:  A Yoshimura; J-H Yuan; A Hashiguchi; Y Hiramatsu; M Ando; Y Higuchi; T Nakamura; Y Okamoto; K Matsumura; T Hamano; N Sawaura; Y Shimatani; S Kumada; Y Okumura; J Miyahara; Y Yamaguchi; S Kitamura; K Haginoya; J Mitsui; H Ishiura; S Tsuji; H Takashima
Journal:  Clin Genet       Date:  2017-04-19       Impact factor: 4.438

2.  Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.

Authors:  S Rudnik-Schöneborn; D Tölle; J Senderek; K Eggermann; M Elbracht; U Kornak; M von der Hagen; J Kirschner; B Leube; W Müller-Felber; U Schara; K von Au; D Wieczorek; C Bußmann; K Zerres
Journal:  Clin Genet       Date:  2015-04-29       Impact factor: 4.438

3.  Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population.

Authors:  Fiore Manganelli; Stefano Tozza; Chiara Pisciotta; Emilia Bellone; Rosa Iodice; Maria Nolano; Alessandro Geroldi; Simona Capponi; Paola Mandich; Lucio Santoro
Journal:  J Peripher Nerv Syst       Date:  2014-12       Impact factor: 3.494

4.  The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4.

Authors:  R Claramunt; T Sevilla; V Lupo; A Cuesta; J M Millán; J J Vílchez; F Palau; C Espinós
Journal:  Clin Genet       Date:  2007-04       Impact factor: 4.438

5.  A family with distal hereditary motor neuropathy and a K141Q mutation of small heat shock protein HSPB1.

Authors:  Kengo Maeda; Ryo Idehara; Akihiro Hashiguchi; Hiroshi Takashima
Journal:  Intern Med       Date:  2014-08-01       Impact factor: 1.271

6.  Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy.

Authors:  Jan Senderek; Carsten Bergmann; Claudia Stendel; Jutta Kirfel; Nathalie Verpoorten; Peter De Jonghe; Vincent Timmerman; Roman Chrast; Mark H G Verheijen; Greg Lemke; Esra Battaloglu; Yesim Parman; Sevim Erdem; Ersin Tan; Haluk Topaloglu; Andreas Hahn; Wolfgang Müller-Felber; Nicolò Rizzuto; Gian Maria Fabrizi; Manfred Stuhrmann; Sabine Rudnik-Schöneborn; Stephan Züchner; J Michael Schröder; Eckhard Buchheim; Volker Straub; Jörg Klepper; Kathrin Huehne; Bernd Rautenstrauss; Reinhard Büttner; Eva Nelis; Klaus Zerres
Journal:  Am J Hum Genet       Date:  2003-10-21       Impact factor: 11.025

7.  Sh3tc2 deficiency affects neuregulin-1/ErbB signaling.

Authors:  Estelle Arnaud Gouttenoire; Vincenzo Lupo; Eduardo Calpena; Luca Bartesaghi; Fanny Schüpfer; Jean-Jacques Médard; Fabienne Maurer; Jacques S Beckmann; Jan Senderek; Francesc Palau; Carmen Espinós; Roman Chrast
Journal:  Glia       Date:  2013-04-02       Impact factor: 7.452

8.  Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy.

Authors:  Z Zhao; A Hashiguchi; J Hu; Y Sakiyama; Y Okamoto; S Tokunaga; L Zhu; H Shen; H Takashima
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

9.  Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.

Authors:  Sauparnika Vijay; Meagan Chiu; Joel B Dacks; Rhys C Roberts
Journal:  Biochim Biophys Acta       Date:  2016-04-09

10.  Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.

Authors:  Yujiro Higuchi; Akihiro Hashiguchi; Junhui Yuan; Akiko Yoshimura; Jun Mitsui; Hiroyuki Ishiura; Masaki Tanaka; Satoshi Ishihara; Hajime Tanabe; Satoshi Nozuma; Yuji Okamoto; Eiji Matsuura; Ryuichi Ohkubo; Saeko Inamizu; Wataru Shiraishi; Ryo Yamasaki; Yasumasa Ohyagi; Jun-ichi Kira; Yasushi Oya; Hayato Yabe; Noriko Nishikawa; Shinsuke Tobisawa; Nozomu Matsuda; Masayuki Masuda; Chiharu Kugimoto; Kazuhiro Fukushima; Satoshi Yano; Jun Yoshimura; Koichiro Doi; Masanori Nakagawa; Shinichi Morishita; Shoji Tsuji; Hiroshi Takashima
Journal:  Ann Neurol       Date:  2016-03-17       Impact factor: 10.422

View more
  4 in total

1.  Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients.

Authors:  Ah Jin Lee; Soo Hyun Nam; Jin-Mo Park; Sumaira Kanwal; Yu Jin Choi; Hyun Jung Lee; Kyung Suk Lee; Ji Eun Lee; Jin-Sung Park; Byung-Ok Choi; Ki Wha Chung
Journal:  J Hum Genet       Date:  2019-06-21       Impact factor: 3.172

Review 2.  Clinical genetics of Charcot-Marie-Tooth disease.

Authors:  Yujiro Higuchi; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-03-18       Impact factor: 3.755

3.  Characteristics of Clinical and Electrophysiological Pattern in a Large Cohort of Chinese Patients With Charcot-Marie-Tooth 4C.

Authors:  Xiaohui Duan; Yan Ma; Dongsheng Fan; Xiaoxuan Liu
Journal:  Front Neurol       Date:  2021-02-12       Impact factor: 4.003

4.  Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients.

Authors:  Bo Sun; Zheng-Qing He; Yan-Ran Li; Jiong-Ming Bai; Hao-Ran Wang; Hong-Fen Wang; Fang Cui; Fei Yang; Xu-Sheng Huang
Journal:  Acta Neurol Belg       Date:  2021-02-15       Impact factor: 2.471

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.